Corneal collagen crosslinking in refractive surgery. 2012

Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
Department of Ophthalmology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA. pchanna@montefiore.org

OBJECTIVE To describe the development and uses of corneal collagen crosslinking (CXL) in association with keratorefractive procedures as well as in the treatment of progressive keratoconus and progressive postlaser in-situ keratomileusis (post-LASIK) keratectasia. RESULTS CXL has been shown to be effective in slowing, halting or reversing progressive ectasia in both keratoconus and progressive post-LASIK keratectasia by means of corneal stiffening. Thus, it is the only treatment option currently available that addresses the underlying progression of ectactic conditions. Combining CXL with keratorefractive procedures, such as intrastromal corneal ring segment implantation and photorefractive keratectomy, is a promising therapeutic alternative to penetrating keratoplasty or lamellar keratoplasty that in many cases can improve visual acuity, stabilize ectasia, and delay or even prevent the need for more invasive procedures. CONCLUSIONS The stiffening effect of CXL has made it a promising alternative in the ophthalmologist's armamentarium for treatment of progressive keratoconus and progressive post-LASIK keratectasia. Future studies are needed to determine the long-term stability of CXL, as well as to address possible complications.

UI MeSH Term Description Entries
D007640 Keratoconus A noninflammatory, usually bilateral protrusion and thinning of the CORNEA, the apex being displaced downward and nasally. It occurs most commonly in females at about puberty. Two closely related noninflammatory corneal ectasias are pellucid marginal degeneration and keratoglobus. Keratoglobus,Pellucid Marginal Corneal Degeneration,Pellucid Marginal Degeneration,Degeneration, Pellucid Marginal,Marginal Degeneration, Pellucid,Pellucid Marginal Degenerations
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003319 Corneal Stroma The lamellated connective tissue constituting the thickest layer of the cornea between the Bowman and Descemet membranes. Corneal Stromas,Stroma, Corneal,Stromas, Corneal
D003432 Cross-Linking Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. Bifunctional Reagent,Bifunctional Reagents,Cross Linking Reagent,Crosslinking Reagent,Cross Linking Reagents,Crosslinking Reagents,Linking Reagent, Cross,Linking Reagents, Cross,Reagent, Bifunctional,Reagent, Cross Linking,Reagent, Crosslinking,Reagents, Bifunctional,Reagents, Cross Linking,Reagents, Cross-Linking,Reagents, Crosslinking
D004108 Dilatation, Pathologic The condition of an anatomical structure's being dilated beyond normal dimensions. Ectasia,Dilatation, Pathological,Dilatations, Pathologic,Dilatations, Pathological,Pathologic Dilatation,Pathologic Dilatations,Pathological Dilatation,Pathological Dilatations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012256 Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as FLAVIN MONONUCLEOTIDE and FLAVIN-ADENINE DINUCLEOTIDE. Vitamin B 2,Vitamin G,Vitamin B2
D014466 Ultraviolet Rays That portion of the electromagnetic spectrum immediately below the visible range and extending into the x-ray frequencies. The longer wavelengths (near-UV or biotic or vital rays) are necessary for the endogenous synthesis of vitamin D and are also called antirachitic rays; the shorter, ionizing wavelengths (far-UV or abiotic or extravital rays) are viricidal, bactericidal, mutagenic, and carcinogenic and are used as disinfectants. Actinic Rays,Black Light, Ultraviolet,UV Light,UV Radiation,Ultra-Violet Rays,Ultraviolet Light,Ultraviolet Radiation,Actinic Ray,Light, UV,Light, Ultraviolet,Radiation, UV,Radiation, Ultraviolet,Ray, Actinic,Ray, Ultra-Violet,Ray, Ultraviolet,Ultra Violet Rays,Ultra-Violet Ray,Ultraviolet Black Light,Ultraviolet Black Lights,Ultraviolet Radiations,Ultraviolet Ray
D014792 Visual Acuity Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast. Acuities, Visual,Acuity, Visual,Visual Acuities

Related Publications

Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
October 2017, Ophthalmology,
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
January 2019, Clinical ophthalmology (Auckland, N.Z.),
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
January 2024, Clinical ophthalmology (Auckland, N.Z.),
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
April 2021, Translational vision science & technology,
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
May 2015, Journal francais d'ophtalmologie,
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
April 2021, Clinical & experimental ophthalmology,
Anjum S Cheema, and Arash Mozayan, and Prabjot Channa
January 2021, Current eye research,
Copied contents to your clipboard!